Emergent Biosolutions (EBS) 30.80 $EBS Glancy Prongay &

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emergent Biosolutions (EBS) 30.80 $EBS

Glancy Prongay & Murray Commences Investigation on Behalf of Emergent BioSolutions, Inc. Investors
BusinessWire - Thu Aug 04, 9:30AM CDT
Glancy Prongay & Murray LLP ("GPM" announces an investigation on behalf of investors of Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning the Company and its officers' possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of injured investors.
EBS: 30.80 (+0.38)

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Emergent Biosolutions, Inc. (EBS) & Lead Plaintiff Deadline: September 19, 2016
ACCESSWIRE - Thu Aug 04, 9:24AM CDT
NEW YORK, NY / ACCESSWIRE / August 4, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court District of Maryland on behalf of those who purchased shares of Emergent Biosolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) during the period between January 11, 2016 and June 21, 2016, inclusive (the "Class Period".
EBS: 30.80 (+0.38)

SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Aug 02, 10:29AM CDT
IRVINE, CA / ACCESSWIRE / August 2, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline.
EBS: 30.80 (+0.38)

Lifshitz & Miller Law Firm Announces Investigation of Ambac Financial Group, Inc., CBL & Associates Properties Inc., Emergent BioSolutions, Inc., Insmed Incorporated, K12 Inc., Lipocine, Inc., and Stericycle, Inc.
PR Newswire - Tue Aug 02, 6:31AM CDT
ATTORNEY ADVERTISING --
INSM: 11.84 (+0.09), EBS: 30.80 (+0.38), AMBC: 18.20 (-0.04), CBL: 12.08 (+0.30), SRCL: 87.79 (-0.20), LPCN: 3.59 (unch), LRN: 12.55 (-0.24)

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. And Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Aug 01, 10:30AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 1, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS) concerning possible violations of federal securities laws between January 11, 2016 and June 21, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 19, 2016 lead plaintiff motion deadline.
EBS: 30.80 (+0.38)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 -- EBS
Marketwired - Mon Aug 01, 10:13AM CDT
NEW YORK, NY--(Marketwired - August 01, 2016) - The following statement is being issued by Levi & Korsinsky, LLP:
EBS: 30.80 (+0.38)

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Aug 01, 10:04AM CDT
IRVINE, CA / ACCESSWIRE / August 1, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 19, 2016 lead plaintiff motion deadline.
EBS: 30.80 (+0.38)

Emergent BioSolutions Completes Spin-Off of Aptevo Therapeutics
GlobeNewswire - Mon Aug 01, 6:00AM CDT
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed its previously announced spin-off of Aptevo Therapeutics Inc. (Nasdaq:APVO) through the distribution of all of the shares of Aptevo common stock to the holders of Emergent BioSolutions common stock. As a result of the spin-off, Aptevo is now an independent public company and listed on the Nasdaq Global Select Market under the ticker symbol "APVO."
EBS: 30.80 (+0.38), APVO: 3.06 (+0.12)

Aptevo Therapeutics Completes Separation from Emergent BioSolutions
BusinessWire - Mon Aug 01, 6:00AM CDT
Aptevo Therapeutics Inc. ("Aptevo" (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today the completion of its separation from Emergent BioSolutions Inc. ("Emergent" (NYSE: EBS) and its launch as an independent, publicly traded corporation. Aptevo common stock will begin "regular way" trading under the symbol "APVO" on the Nasdaq Global Select Market today, August 1, 2016.
EBS: 30.80 (+0.38), APVO: 3.06 (+0.12)

EMERGENT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS
Marketwire Canada - Fri Jul 29, 9:07PM CDT
NEW ORLEANS, LA--(Marketwired - July 29, 2016) - Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 19, 2016 to file lead plaintiff applications in a securities class action lawsuit against Emergent BioSolutions, Inc. (NYSE: EBS), if they purchased the Company's securities between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the District of Maryland.
EBS: 30.80 (+0.38)

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Emergent BioSolutions Inc.
GlobeNewswire - Fri Jul 29, 2:19PM CDT
Rigrodsky & Long, P.A.:
EBS: 30.80 (+0.38)

SHAREHOLDER ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important Deadline in Class Action
BusinessWire - Fri Jul 29, 1:26PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Emergent BioSolutions, Inc. common stock (NYSE:EBS) from January 11, 2016 through June 21, 2016, both dates inclusive (the "Class Period" of the important September 19, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Emergent BioSolutions investors under the federal securities laws.
EBS: 30.80 (+0.38)

SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Encourages Investors with Losses to Contact the Firm
BusinessWire - Fri Jul 29, 11:21AM CDT
Goldberg Law PC (the "Firm" announces that a class action lawsuit has been filed against Emergent BioSolutions, Inc. ("Emergent" or the "Company" (NYSE: EBS). Investors who purchased or otherwise acquired shares between January 11, 2016 and June 21, 2016 (the "Class Period" are encouraged to contact the Firm in advance of the September 19, 2016 lead plaintiff motion deadline.
EBS: 30.80 (+0.38)

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Emergent Biosolutions, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
BusinessWire - Fri Jul 29, 10:14AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Maryland, Southern Division, on behalf of purchasers of Emergent Biosolutions, Inc. (NYSE: EBS) ("Emergent" or the "Company" common stock during the period between January 11, 2016 and June 21, 2016, inclusive (the "Class Period". Emergent is headquartered in Gaithersburg, Maryland. Brower Piven is the only firm headquartered in Maryland with a practice dedicated primarily to shareholder class action litigation.
EBS: 30.80 (+0.38)

Emergent BioSolutions Announces Effectiveness of Aptevo Therapeutics Form 10 Registration Statement
GlobeNewswire - Fri Jul 15, 12:17PM CDT
-- Aptevo Therapeutics common stock approved for listing on the NASDAQ Global Select Market
EBS: 30.80 (+0.38)

Should You Get Rid of Emergent BioSolutions (EBS) Now?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 7:35AM CDT
One stock that you may want to consider dropping is Emergent BioSolutions (EBS), which has witnessed a significant price decline in the past four weeks
EBS: 30.80 (+0.38), ENZ: 6.70 (-0.05)

Emergent BioSolutions to Implement Stock Repurchase Program for Up to $50 Million of Its Common Stock
GlobeNewswire - Fri Jul 15, 6:00AM CDT
Emergent BioSolutions Inc. (NYSE:EBS) today announced that its Board of Directors has authorized the company's management to implement a stock repurchase program for up to $50 million of the company's common stock from time to time on the open market or in privately negotiated transactions.
EBS: 30.80 (+0.38)

Ligand (LGND) Signs Deal with Gilead for OmniAb Technology
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 10:00AM CDT
Ligand (LGND) announced that it has entered into a worldwide license agreement with Gilead (GILD) for OmniAb Technology.
EBS: 30.80 (+0.38), INVA: 12.86 (-0.15), GILD: 79.78 (-0.31), LGND: 133.13 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading